Minireviews
Copyright ©The Author(s) 2022.
World J Gastroenterol. Jun 21, 2022; 28(23): 2561-2568
Published online Jun 21, 2022. doi: 10.3748/wjg.v28.i23.2561
Table 1 Considerations in initiating systemic therapy over transarterial chemoembolization[26,44,53-55]
No.
Considerations
1Tumor exceeds “the up to seven" criteria
2Tumor(s) larger than 5cm
3Contiguous multinodular tumors
4Poorly differentiated or undifferentiated HCC
5No objective response to 2 consecvutive TACE treatments